APPLICATION
ANDA210283
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-27
LATEST ACTION
2021-03-31
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
CLOFARABINEDiscontinued
CLOFARABINE 20MG/20ML (1MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2021-03-31Labeling · Supplement 1 · standardAP
2018-12-27UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.